BACKGROUND: Individual patient data meta-analyses (IPD-MA) are often performed using a one-stage approach-- a form of generalized linear mixed model (GLMM) for binary outcomes. We compare (i) one-stage to two-stage approaches (ii) the performance of two estimation procedures (Penalized Quasi-likelihood-PQL and Adaptive Gaussian Hermite Quadrature-AGHQ) for GLMMs with binary outcomes within the one-stage approach and (iii) using stratified study-effect or random study-effects. METHODS: We compare the different approaches via a simulation study, in terms of bias, mean-squared error (MSE), coverage and numerical convergence, of the pooled treatment effect (β (1)) and between-study heterogeneity of the treatment effect (Ï (1)(2) ). We varied the prevalence of the outcome, sample size, number of studies and variances and correlation of the random effects. RESULTS: The two-stage and one-stage methods produced approximately unbiased β (1) estimates. PQL performed better than AGHQ for estimating Ï (1)(2) with respect to MSE, but performed comparably with AGHQ in estimating the bias of β (1) and of Ï (1)(2) . The random study-effects model outperformed the stratified study-effects model in small size MA. CONCLUSION: The one-stage approach is recommended over the two-stage method for small size MA. There was no meaningful difference between the PQL and AGHQ procedures. Though the random-intercept and stratified-intercept approaches can suffer from their underlining assumptions, fitting GLMM with a random-intercept are less prone to misfit and has good convergence rate.
A comparison of analytic approaches for individual patient data meta-analyses with binary outcomes.
阅读:3
作者:Thomas Doneal, Platt Robert, Benedetti Andrea
| 期刊: | BMC Medical Research Methodology | 影响因子: | 3.400 |
| 时间: | 2017 | 起止号: | 2017 Feb 16; 17(1):28 |
| doi: | 10.1186/s12874-017-0307-7 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
